Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project

@inproceedings{Bandak2017HyperkalemiaAI,
  title={Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project},
  author={Ghassan Bandak and Yingying Sang and Alessandro Gasparini and Alex R Chang and Shoshana H. Ballew and Marie Evans and Johan Arnlov and Lars H. Lund and Lesley Ann Inker and Josef Coresh and Juan‐Jesus Carrero and Morgan E Grams},
  booktitle={Journal of the American Heart Association},
  year={2017}
}
BACKGROUND Concerns about hyperkalemia limit the use of angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARBs), but guidelines conflict regarding potassium-monitoring protocols. We quantified hyperkalemia monitoring and risks after ACE-I/ARB initiation and developed and validated a hyperkalemia susceptibility score. METHODS AND RESULTS We evaluated 69 426 new users of ACE-I/ARB therapy in the Stockholm Creatinine Measurements (SCREAM) project with medication… CONTINUE READING
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Similar Papers

Loading similar papers…